WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009124294) PHARMACEUTICAL COMPOSITIONS FOR BINDING SPHINGOSINE-1-PHOSPHATE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/124294    International Application No.:    PCT/US2009/039555
Publication Date: 08.10.2009 International Filing Date: 03.04.2009
IPC:
A61K 39/395 (2006.01), C12P 21/08 (2006.01)
Applicants: LPATH, INC. [US/US]; 6335 Ferris Square, Suite A San Diego, CA 92121-3249 (US) (For All Designated States Except US).
SABBADINI, Roger, A. [US/US]; (US) (For US Only).
PANCOAST, Scott, R. [US/US]; (US) (For US Only).
HANSEN, Genevieve [US/US]; (US) (For US Only).
GARLAND, William, A. [US/US]; (US) (For US Only).
SAFONOV, Marina [US/US]; (US) (For US Only)
Inventors: SABBADINI, Roger, A.; (US).
PANCOAST, Scott, R.; (US).
HANSEN, Genevieve; (US).
GARLAND, William, A.; (US).
SAFONOV, Marina; (US)
Agent: CHAMBERS, Daniel, M.; BioTechnology Law Group 12707 High Bluff Drive Suite 200 San Diego, CA 92130-2037 (US)
Priority Data:
61/042,736 05.04.2008 US
Title (EN) PHARMACEUTICAL COMPOSITIONS FOR BINDING SPHINGOSINE-1-PHOSPHATE
(FR) COMPOSITIONS PHARMACEUTIQUES DESTINÉES À LIER LA SPHINGOSINE-1-PHOSPHATE
Abstract: front page image
(EN)The present invention relates to compositions that comprise an anti-SIP monoclonal antibody, antibody fragment, or derivative in a carrier, particularly a buffered, hypertonic aqueous solution, as well as to kits containing such compositions, and methods for using such compositions for treatment of diseases and conditions associated with SlP.
(FR)La présente invention concerne des compositions qui comprennent un anticorps monoclonal anti-SIP, un fragment ou dérivé d'anticorps dans un vecteur, en particulier une solution aqueuse hypertonique tamponnée, ainsi que des kits contenant ces compositions, et des procédés d’utilisation de ces compositions pour le traitement de maladies et de conditions associées à SIP.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)